Format

Send to

Choose Destination
Cell Mol Life Sci. 2013 Jun;70(12):2139-57. doi: 10.1007/s00018-012-1161-8. Epub 2012 Sep 25.

Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Author information

1
Department of Clinical and Molecular Medicine, University La Sapienza, Rome, Italy.

Abstract

Melatonin is involved in many physiological functions and it plays an important role in many pathological processes as well. Melatonin has been shown to reduce the incidence of experimentally induced cancers and can significantly inhibit the growth of some human tumors, namely hormone-dependent cancers. The anticancer effects of melatonin have been observed in breast cancer, both in in vivo with models of chemically induced rat mammary tumors, and in vitro studies on human breast cancer cell lines. Melatonin acts at different physiological levels and its antitumoral properties are supported by a set of complex, different mechanisms of action, involving apoptosis activation, inhibition of proliferation, and cell differentiation.

PMID:
23007844
DOI:
10.1007/s00018-012-1161-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center